P05.05 Safety and feasibility of temporary blood-brain barrier disruption with the SonoCloud-1/3 implantable ultrasound device in recurrent glioblastoma

BACKGROUND: The blood-brain barrier (BBB) limits penetration of drug therapies to the brain and may account for the limited effectiveness of chemotherapies in patients with primary brain cancer. An implantable ultrasound (US) device, SonoCloud, was developed to temporarily disrupt the BBB in patient...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Idbaih, A, Canney, M, Bouchoux, G, Desseaux, C, Vignot, A, Lafon, C, Chapelon, J, Delattre, J, Belin, L, Carpentier, A
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Poster Presentations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796056/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.119
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы